| 来源类型 | Publication |
| Healthcare Costs Associated with Escitalopram and Alternative SSRIs | |
| Dominick Esposito; Peter Wahl; Gregory Daniel; Michael A. Stoto; and Thomas W. Croghan | |
| 发表日期 | 2011-09-01 |
| 出版者 | American Journal of Pharmacy Benefits, vol. 3, no. 5 |
| 出版年 | 2011 |
| 语种 | 英语 |
| 概述 | To compare healthcare costs associated with initiating treatment on escitalopram or an alternative selective serotonin reuptake inhibitor.", |
| 摘要 | To compare healthcare costs associated with initiating treatment on escitalopram or an alternative selective serotonin reuptake inhibitor. |
| URL | https://www.mathematica.org/our-publications-and-findings/publications/healthcare-costs-associated-with-escitalopram-and-alternative-ssris |
| 来源智库 | Mathematica Policy Research (United States) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/486903 |
| 推荐引用方式 GB/T 7714 | Dominick Esposito,Peter Wahl,Gregory Daniel,et al. Healthcare Costs Associated with Escitalopram and Alternative SSRIs. 2011. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
